Dr. Michael Tuttle on Dosimetry Versus Empiric Dosing Radioactive Iodine Treatment
Published: | Updated:
Michael Tuttle, MD, endocrinologist Memorial Sloan Kettering (MSK), discusses best management approaches to radioactive iodine treatment in patients with radioiodine avid distant metastases from differentiated thyroid cancer.
